►
Description
No description was provided for this meeting.
If this is YOUR meeting, an easy way to fix this is to add a description to your video, wherever mtngs.io found it (probably YouTube).
A
E
A
I
am
here
all
right:
we
have
a
quorum
established
to
do
business,
so
I
will
just
go
ahead.
A
Okay,
we
are
limited
to
an
hour,
so
we
will
go
ahead
and
get
started.
If
you
can.
This
is
house
bill
95,
which
we
will
be
discussing
now.
Representative
bentley
is
the
sponsor.
If
you
can
just
introduce
your
guest
or
you
can
introduce
yourselves
and
please
proceed.
C
I
I'm
representative
patty
mentor,
I
represent
bowling,
green's
house
district
20
and
I
am
a
proud
mother
of
a
son
who
lives
with
type
1
diabetes
and
proud
to
work
with
this
gentleman
on
this
important
legislation.
A
Thank
you.
Would
you
like
to
adopt
the
committee
sub.
C
C
C
A
C
Man
sure
there's
someone
on
zoom.
I
think
that
needs
to
speak
about
a
minute
before
maybe
taking
the
vote,
her.
D
A
A
Do
that
all
right,
mrs
lautner,
if
you
would
like
to
proceed,
thank
you.
K
Hello,
everyone.
Thank
you,
chairwoman,
moser
for
this.
I
am
not
really
going
to
take
up
any
more
time.
I
just
want
to
remind
everyone,
this
vial
of
insulin.
It
doesn't
cost
any
more
than
six
dollars
and
16
cents
to
make
the
copay
cap
here
for
30
dollars,
which
will
apply
to
state
employees
and
people
who
purchase
their
plans
on
the
marketplace
exchange.
K
It's
a
copay
cap
limit
at
thirty
dollars.
So
just
always
remember,
this
vial
does
not
cost
any
more
than
six
dollars
to
make,
and
we
would
appreciate
a
unanimous,
yes
vote
today.
I
And
I
can
add
very
little
to
that.
This
is
except
to
say
for
those
of
you
who
were
part
of
this
body
last
year.
This
is
a
better
bill
than
the
one
that
this
body
passed
92-0
last
year
and
then
it
disappeared
on
right
before
signing
die.
I
hope
it's
going
to
go
all
the
way
this
year
the
cap
is
lower
in.
I
It
is
also
we
learned
from
our
constituents
that
we
needed
to
expand
this
to
apply
to
people
in
the
state
plan,
so
this
bill
has
will
cover
more
people
than
it
did
last
year.
The
copay
is
better.
I
We
still
have
a
lot
of
work
to
do
to
get
to
the
point
where,
as
angela
correctly
points
out,
it
cost
six
dollars
to
make
that
vial.
The
last
time
I
had
my
son
filled
a
prescription
for
a
30-day
supply.
It
was
over
150
dollars,
so
on
behalf
of
everyone
in
kentucky
who
lives
with
diabetes,
type
1
and
type
2.
I
L
A
All
right,
thank
you,
representative
westrom.
I
I
would
just
like
to
add
that
I
have
had
a
a
very
positive
meeting
with
the
personnel
cabinet
who
had
some
concerns
and
you
address
those
and
they
are
very
grateful.
So
thank
you.
Yes,.
D
B
D
D
D
M
H
L
L
A
Yes,
thank
you
house
bill
95,
as
amended
by
committee,
sub
2
passes
with
unanimous
support.
A
A
C
A
C
So
it's
an
update
and
it's
a
good
thing,
because
we
don't
stigmatize
those
people
and
we
can
get
more
information
to
them
when
we
do
this.
So
the
board
of
pharmacy
came
to
me
to
update
this
language
and
so
what
it
does.
It
deletes
the
retail
record,
keeping
requirements
for
the
cell
hypodermic
needles.
A
C
A
All
right,
all
in
favor
any
opposed
all
right.
We
also
have
a
house
committee
amendment
to.
C
A
A
C
It
deletes
the
retail
pharmacy
record,
keeping
requirements
for
the
cell
hypodermic
needles.
It
adds
two
provisions
for
the
sale
of
hypodermic
needles
for
individuals
without
a
prescription.
C
So
this
establishes
a
physical
or
electronic
information
on
the
safe
cell
and
proper
use,
also
as
a
physical
and
electronic
education
referral
information
on
substance,
abuse
and
treatment,
and
a
verbal,
physical
or
electronic
offer
to
provide
a
naloxone
which
is
narcan
for
opioid
overdose
and
also
a
verbal
physical
electronic
offer
to
provide
the
purchaser's
name
and
contact
information
to
a
local
public
health
substance
use
disorder.
Outreach
provides
that
the
seller
may
be
inspected
during
business
hours
by
any
law
enforcement
officer
or
an
agent
or
employee
of
chfs
or
the
board
of
pharmacy.
C
The
committee
stub
removes
the
cell
limits
on
syringes
to
30
per
person,
and
it
removes
the
proof
of
age.
After
we
looked
at
it,
we
figured
it
kind
of
was
too
stigmatizing
and
30
was
too
limited,
and
if
you
just
think
about
it,
you
would
understand
why
I'll.
Let
steve
speak
on
that
in
a
second.
But
let
me
also
talk
about
the
amendment
to
the
sub.
C
M
Doc,
representative
bentley
did
a
great
job,
taking
care
of
that.
The
additional
language
that
we
added
concerning
pharmacy
remote
work
was
really
narrowed.
Down,
tailored
down
to
just
three
types
of
data
entry.
They
can
do,
we've
really
nailed
down
that
no
dispensing
can
happen
off-site
we've
really
taken
care
of
of
any
concerns
that
you
know
that
that
we
feel
could
be
unintended
consequences.
M
We'd
be
open
to
any
floor
amendments.
If
somebody
at
some
point
wants
to
bring
something
else
up,
but
I
think
dr
bentley's
done
a
good
job
getting
this
thing
wrapped
up,
so
I
feel
I
support
it
fully
ocean
on
the
bill.
A
Okay,
we
have
a
motion
in
a
second,
we
we
have
a
question
from
representative
weber:
okay,.
H
Actually
more
of
a
a
comment,
madam
chair,
I
want
to
thank
representative
bentley
representative
sheldon
for
for
your
work
on
this,
especially
the
the
addition
here
of
this
amendment
for
the
remote
work
done
with
the
pharmacies.
This
directly
affects
my
constituents
in
my
district.
I
have
a
large
employer
in
my
district
that
has
been
doing
this
and
will
allow
them
to
continue
to
do
it,
and
then
I
there's
another
facility
on
fern
valley,
road
in
louisville.
H
That
probably
has
close
to
100
of
my
constituents
who
worked
there,
who
would
benefit
from
this,
and
I
think
this
will
be
open
up
for
allow
for
for
the
recruitment
of
new
businesses
coming
into
the
state
with
this,
this
opportunity
to
exist.
So
I
want
to
thank
you
for
for
bringing
that
forward
and
agreeing
to
allow
your
bill
to
be
amended
so
that
we
could
truly
help
the
folks
in
this
state.
So
I
appreciate
it.
Thank
you,
gentlemen.
Thank
you.
A
Thank
you,
representative,
tate
again.
N
I'd
like
to
thank
you
both
for
bringing
this
before
us,
you
know
many
other
states
allow
this
type
of
flexibility
and
enacting
this
language
into
statute
obviously
gives
us
the
the
flexibility
and
businesses
the
flexibility
for
planning
and
investment,
trying
to
make
sure
that
kentucky
remains
a
leader
in
attracting
more
of
these
high
paid
pharmacists
and
pharmacy
technician
jobs.
So
I
absolutely
applaud
you
for
doing
that.
N
The
only
thing
that
I
want
to
express
concern
about
is
that,
and
I've
expressed
concern
about
this
whenever
you
talk
about
remote
work,
I
totally
agree
with
that.
You
know
I
always
say
that
if
we
can
outsource
to
india,
we
can
outsource
to
eastern
kentucky.
So
the
only
thing
that
my
concern
is
is
that
outsource
word
is
that
I
do
not
want
there
to
be
any
flexibility
in
this
statute
that
would
allow
for
the
outsourcing
to
occur
to
other
countries.
M
That's
a
valid
concern,
and,
and
actually
we
rolled
in
an
amendment
to
that
sub-
that
actually
said,
whoever
we're
outsourcing
this
to
has
to
be
licensed
in
kentucky
the
tech
or
the
pharmacist.
So
we're
making
sure
that
those
employees
stay
right
here.
M
Representative
weber
indicated
several
there's
at
least
a
couple
thousand
employees
that
are
affected
by
this,
and
I
agree
with
with
both
of
you.
I
believe
other
operations
such
as
this,
these
closed
door
operations
that
deal
with
rebates
from
manufacturers
and
they're
processing.
These
things,
all
the
time,
they're
doing
a
great
service
for
our
consumers
and
our
and
people
for
their
health
plus
they're
doing
it
right
here
in
kentucky.
I
think
those
type
of
operations
will
like
this,
and
I
think,
they'll
look
at
kentucky
for
for
now
more
of
an
opportunity
to
come
here.
J
Yes,
my
question
you:
when
you
mentioned
what
was
in
it,
you
said
something
about
a
to
let
the
person
know
about
potential
treatment.
I
don't
see
this
in
the
committee
sub.
Did
you
take
it
out
or
is
it
somewhere
else?
Did
I
miss
it?.
M
J
M
A
Thank
you,
of
course,
representative
fleming.
F
Thank
you,
ma'am
chair.
I
want
to
express
a
deep
appreciation
for
the
chair
as
well
as
representative
they're
presenting
this
bill.
I
work
with
them
on
trying
to
get
some
clarification
and
I've
been
representative.
Bentley,
always
harasses
me
about
being
a
numbers
guy,
and
I
harass
him
for
being
a
pharmacist
guy,
but
I
totally
respect
where
he's
coming
from.
He
always
puts
forth
very
thoughtful
bills.
F
I
just
want
to
put
some
numbers
representative,
bentley
representative
miller
weber,
mentioned
about
his
constituents
in
jefferson,
county
there's
around
2000
or
more
individuals
that
are
working
in
jefferson
county
and
when
you
look
at
that
and
go
through
some
calculations
you're
looking
at.
If
this
wasn't
in
there
you're
looking
at
around
13
to
15
million
dollars
that
could
potentially
leave
the
state-
and
I
know
that's
not
the
intent,
because
we
need
to
keep
the
jobs
here
and
so
forth.
F
So
so,
in
doing
that,
I
do
appreciate
both
y'all
working
with
me
and
others
and
making
this
happen,
and
I
also
want
to
point
out
representative
tate
in
terms
of
outsourcing
when
I
was
chairman
of
our
mapping
association,
we
came
across
that
quite
a
bit
in
terms
of
outsourcing
other
countries,
and
so
what
we
do
to
insourcing,
as
we
might
say
in
kentucky
that'd,
be
great,
but
I
do
appreciate
both
y'all
working
hard
on
this,
and
I
appreciate
your
consideration
in
doing
this.
So
thank
you.
A
Okay,
thank
you
very
much.
I
would
just
like
to
also
applaud
you
for
your
work,
and
I
know
that
this
has
been
kind
of
a
long
week,
late
nights
working
on
this
amendment
and
making
sure
that
the
kentucky
board
of
pharmacy
is
included
in
the
discussion
as
well
as
all
of
the
folks
here
who
are
very
supportive
of
this
language.
So
I
know
that
we
have
some
folks
from
the
board
of
pharmacy
here
to
either
answer
questions.
I
don't
know
if
you
wanted
to
make
a
quick
comment.
E
E
A
D
A
D
O
Okay,
well,
thank
you
so
much
for
your
patience.
First
of
all,
and
thank
you
for
the
time
to
speak
today.
Obviously,
you
know
this
is
a
very
important
bill
for
us
at
the
board
of
pharmacy
hb
219,
and
thank
you
for
hearing
it
and
thank
you
to
the
sponsors,
given
that
the
the
syringe
there
does
not
seem
to
be
a
lot
of
a
question
about
that.
O
I
won't
go
through
that
in
detail,
but
honestly,
like
changes
to
218
a
dot
500
in
tandem
with
krs-217.777
would
really
allow
pharmacists
to
improve
and
participate
in
important
harm
reduction
strategies
that,
I
think,
would
serve
our
community
and
our
state
much
better,
and
I
think
we
have
a
lot
of
work
that
we
can
contribute
to
that's
already
ongoing.
O
O
So
we've
been,
you
know,
that's
been
wonderful.
It's
been
very
helpful.
O
We
were
asked
as
a
board
of
pharmacy
in
may
of
2020
to
consider
whether
remote
order
entry
should
be
allowed
as
a
permanent
practice
change,
and
the
board
did
issue
an
opinion
on
this
and
did
not
believe
new
action
was
needed
to
allow
for
a
permanent
practice
change
at
that
time.
Given
that
the
board
of
pharmacy
had
the
ability
to
invoke
emergency
pharmacy
powers
already
in
response
to
emergencies
such
as
covid
pandemic
and
others,
and
so
you
know
making
a
statutory
change
that
affects
the
specific
pharmacy
practice
may
be
premature.
O
At
this
point,
the
board
of
pharmacy
is
actively
working
with
other
organizations,
including
the
kentucky
department
of
public
health
to
proactively,
evaluate
and
make
thoughtful
and
safe
professional
pharmacy
practice.
Changes
based
on
both
the
pandemic
impact
and
the
appropriate
steps
to
best
take
care
of
patients
in
kentucky.
O
We
are
charged
as
a
board
to
protect
the
public
and
the
practice.
Change
should
be
given
a
thorough
vetting
and
have
consideration
expertise
from
all
stakeholders
in
pharmacy
practice
at
the
board
of
pharmacy.
There
are
some
potential
unintended
consequences
that
place
some
limitations
on
pharmacy
practice.
The
way
it's
currently
posed
and
potentially
safety
concerns,
limitations
to
access
to
care
or
fearing
of
patients
to
particular
entities.
O
So,
given
that
the
application
has
a
widespread
impact,
I
do
feel
that
there
may
be
some
considerations
that
our
agency
could
make,
and
I
would
ask
that
perhaps
that
later
part
of
the
bill
be
considered,
removed,
potentially
or
amended,
if
possible,
so
that
our
board
of
pharmacy
can
evaluate
that
practice.
Change
as
we
currently
are.
O
F
A
Second,
we
have
a
motion
in
a
second
again.
I
just
appreciate
your
work
and
I
I
really
appreciate
the
car
the
harm
reduction
language
as
well.
I
think
we,
we
are
solving
a
few
problems
with
one
stone:
okay,
we
will
go
ahead
and
take
the
roll.
Please.
D
D
M
D
C
M
Yes-
and
I
would
like
to
say,
explain
that,
yes
for
the
last
week
or
so,
this
language
has
been
in
the
in
the
hands
of
folks
at
the
board
of
pharmacy
and
we're
more
than
in
tune
to
listen
to
more.
We
made
several
changes
as
a
result
of
that.
We're
more
we're
real
happy
to
see
any
more
language
changes,
and
I
can
do
that
in
the
floor
amendment.
So
yes,.
D
D
A
Yes,
classes,
we
have
a
title
amendment
which
we
need
to
adopt.
A
Okay,
okay:
first,
we
need
to
roll
the
amendment
into
the
committee
sub.
We
need
a
motion
committee.
Thank
you.
We
have
a
motion
a
second
all
in
favor
aye
any
opposed.
Okay.
Thank
you.
Now
we
have
the
title
amendment
to
adopt.
A
We
have
a
motion
on
the
title
amendment.
Do
we
have
a
second?
Thank
you
all
in
favor
aye
any
opposed?
Okay.
Thank
you
very
much
house
bill
219,
as
amended
by
house
committee
sub
three
and
the
title
amendment
passes
favorably
and
the
same
should
pass
on
the
house.
A
Okay,
since
this
is
the
representative,
bentley
and
representative
sheldon
show
today
they
will
stay
put
at
the
table
and
discuss
house
bill
222.,
please
introduce
yourselves
and
proceed.
Thank
you.
M
M
Okay,
let's,
this
is
really
something
we
heard
over
the
interim,
but
those
are
familiar
with
senate
bill
50..
We
went
to
a
single
pbm
method
to
take
care
of
our
medicaid
claims
here
in
the
state
of
kentucky.
The
good
news
is
that
is
moving
along
just
fine.
I've
been
in
contact
with
the
cabinet,
they're
things
are
looking
up
and
and
they're
working
hard
they've
had
a
lot
to
go
through
so
they're
fully.
M
Behind
that
this,
this
particular
bill
was
was
an
idea
that
came
to
us
over
the
interim,
and
it
basically
just
offers
an
oversight
for
the
cabinet
to
base
to
put
together
or
take
procurement
on
a
entity
that
would
oversee
the
implementation
of
not
only
senate
bill
50,
but
moving
forward
beyond
that,
and
actually
taking
a
look
at
all
the
claims
that
that
get
processed
for
medicaid
and
checking
them
for
errors
and
just
being
an
oversight
entity-
and
we
put
a
lot
of
language
in
here
that
that
would-
and
I've
talked
to
the
cabinet
just
even
recently
within
the
last
week-
and
there
were
some
concerns
they
had.
M
We've
made
some
changes
for
them,
but
this
is
meant
to
help
the
cabinet.
It's
meant
to
to
help
the
any
errors
that
are
found
make
the
the
pharmacies
whole
if
they're,
if
they're
found
to
be
to
be
underpaid
or
and
if
the
cabinet,
if
the
taxpayer
is
found
to
be
an
issue
with
the
pbm
this
this
entity
will
catch
it.
M
So
it's
basically
an
oversight
to
the
medicaid
claims
that
go
on
here
in
kentucky
and
there's
a
lot
that
I
could
get
into
the
details
here
with,
but
but
I'll
stop
there
and
let
dr
bentley
add
to
that.
A
C
Man,
charlie
the
committee
sub,
we
we,
after
we
read
this
several
times
and
if
we
had
this
entity
doing
this
job,
we
realized
that
we
had
to
monitor
them
too.
So
we
have
limited
that
duration
to
two
years,
and
so,
if
they
would
take
the
contract
with
the
dms,
they
may
be
renewed
for
periods
up
to
two
years,
so
the
total
compensation
paid
by
the
dms
to
the
contracted
entity,
we
don't
know
who
they
are
during
the
initial
two-year
contract-
is
capped
at
30
percent
and
there's
a
good
reason
for
that.
C
C
Okay,
that's
our
job
as
pharmacists
and
they
you
know
it
wouldn't
be
their
entity,
so
a
process
for,
and
doctors
and
nurses
and
everybody
else
all
the
professionals
that
do
that.
Don't
leave
anybody
out
a
process
for
resolving
underpayments
disputes
has
been
established
also,
so
the
provisions
of
that
substitute
this
act
will
sunset
and
expire
on
january,
the
1st
2024.
C
M
Just
the
cabinet
had
some
concerns
about
having
some
time
to
get
sent
a
bill
50
underneath
their
feet
and
get
it
implemented.
It
made
all
the
sense
in
the
world
to
to
not
really
you
know,
to
kind
of
test
and
make
this
almost
a
pilot
for
a
couple
of
years.
Let
it
sunset
out
not
put
them
under
the
situation
where
they
may
get
stuck
in
a
in.
Maybe
in
a
situation,
because
this
is
new,
I
mean
the
whole
country
is
watching
the
single
pbm
program,
this
senate
bill
50
was
new.
This
is
brand
new.
M
Nobody
else
is
doing
this,
so
they're
going
to
be
under
a
microscope.
We
don't
want
them.
We
don't
want
to
flood
them
with
with
with
rfps
and
procurements
all
at
once.
So
I
think
the
cabinet
was
really
upbeat
about
this.
After
we
they
knew
it
wouldn't
start
till
january
1.,
there's
senate
bill.
M
50
should
be
implemented
by
seven
or
eight
months
by
then
they'll
be
they'll,
be
under
their
feet,
and
this
company
should
come
along
as
a
partner
to
them
and
help
them
make
sure
that
the
single
pbm
is
acting
in
good
faith
and
we
suspect
they
will
be,
but
we
found
out
in
the
past.
Sometimes
that's
not
the
case.
L
M
M
D
M
Here
in
the
house
once
a
quarter
to
let
us
know
and
again
we
we
kept
their
ability
to
make
no
more
than
30
percent
of
what
they
find
but
yeah.
It
won't
cost
us
a
nickel,
and
then
we
also
made
sure
that,
because
we
have
done
studies
in
the
past,
that
that
were
astronomically
high
of
what
the
pbms
had
overcharged.
M
M
No
there'll
be
a
procurement
process
and
there's
at
least
two
or
three
entities
that
that
can
do
this
kind
of
work.
If
not
more,
and
we
don't
know
who
that'll
be.
A
Okay,
thank
you
so
much
for
your
presentation
again.
Thank
you
so
much
for
your
work.
I
know
that
a
lot
of
work
went
into
this.
I
I
was
happy
to
be
part
of
those
conversations.
A
It's
exciting
to
see
what
sort
of
savings
we
save,
what
we
see
generated
by
simply
moving
to
a
single
pbm
on
a
state
level,
but
then
also
adding
this
additional
oversight
in
partnership
with
the
cabinet.
This
is
really
a
support
mechanism
and
a
reporting
mechanism
to
the
legislature.
I
think
it's
a
very
smart
proposal,
so
thank
you
for
bringing
it
do.
We
have
any
further
questions.
F
Thank
you
matt.
Thank
you.
Ma'am
chair,
just
curiosity,
have
y'all
gone
through
and
did
any
type
of
pro
forma
on
estimating
the
savings.
M
We
have
a
different
opinion.
We
for
several
years,
have,
if
you
haven't
seen
it
yet,
you
got
to
go.
Look
at
the
black
box
study
and
other
types
of
studies
we've
done
in
previous
administration
as
well
as
this
one
has
been
very
on
the
ball.
I
know,
commissioner
lee
had
made
a
comment
that
she
was
excited
about,
implementing
this
single
pbm
and
and
that
it
was
looking
good
so
far.
M
So
that's
that's
all
I
can
say
right
now,
but
I
think
there's
some
good
things
coming,
but
as
far
as
what
it
could
be,
I
hate
to
spit
out
numbers
because
the
numbers
are
really
big
and
there's
a
reason.
We
have
a
30
cap
on
how
much
they
can
how
much
they
find
so
so
the
numbers
are
are
significant
that
we
found
prior
to
coming
up
with
this
single
pbm
thing
and
then,
by
the
way
there
were
some
protests
to
the
single
pbm.
M
There
was
all
this
lobbyist
saying
that
you
know
this
wasn't
going
to
be
approved
by
medicare
medicaid.
You
know
that
it
all
the
protests
are
gone,
all
the
they're.
They
were
all
dropped
last
week
and
they
were
really
just
protests
by
the
people
that
didn't
get
the
bid
for
bbm.
It
wasn't
by
medicare,
so
it
was
all
misconstrued.
The
good
news
is,
we
got
a
green
light,
we're
heading
forward
and
I
think
that
number
will
be
significant.
F
Wow
this
is,
this
is
brilliant.
I
think
this
is.
This
is
a
great
testimony
of
y'all's
ingenuity,
insight
and
getting
this
getting
through.
I
did
want
to
just
add
some
advice,
and
I
don't
know
where
to
add
this,
but
but
making
sure
make
sure
that
we
look
at
the
procurement
process
and
not
do
it
solely
on
price.
J
F
F
So
I
encourage
all
to
make
sure
that
materializes
and
so
forth
and
that'll
be
very,
very
helpful
and
we've
gone
through,
and
the
chair
knows
that
we've
gone
through
a
credentialing
process
for
for
health
providers,
and
now
we
got
to
re-engineer
that
because
that
didn't
turn
out
as
much
as
as
well
as
we
thought.
So.
Thank
you
very
much
for
your
ingenuity
and
creativity.
C
A
Significant
okay,
thank
you.
So
much
see
no
further
questions
secretary.
Please
take
the
we
had
a
motion,
but
we
don't
have
a
second
thank.
You
represent
bray,
okay,.
C
D
M
H
A
A
Thank
you
before
we
move
on
to
the
next
two
to
the
last
two
bills
which
I
will
present.
I
would
just
like
to
point
out
that
we
do
have
a
status
report
on
the
block
grants
having
to
do
with
child
care
and
development
funds.
The
community
service
block,
grant
social
services
block,
grant
and
temporary
assistance
for
needy
families
or
tanf
block
grant.
This
is
just
for
our
information.
Only
all
of
that
information
has
been
shared
with
the
committee.
We
also
need
to
consider
nine
regs.
A
All
regs
have
been
reviewed
by
our
staff,
our
myself
and
were
sent
to
all
committee
members.
Do
we
have
any
questions
about
any
of
the
regs
all
right?
We
need
a
well.
A
Okay,
all
right
so
consider
those
regs
reviewed
and
approved.
Okay,
I
will
hand
over
the
gavel
to
my
vice
chair,
make
my.
A
D
I'd
like
to
record
yes
votes
for
house
bill,
95
and
also
house
bill
219.
A
Thank
you,
madam
chair,
and
I
appreciate
the
opportunity
to
present
these
bills
to
you.
I
am
representative
kim
mosher
of
the
64th
district
and
first
I
would
like
to
discuss
house
bill
276.
with
me.
I
have
a
few
guests.
A
It
requires
the
department
for
medicaid
services
to
accept
the
employment
of
temporary
cove
personal
care
attendance
as
having
met
the
necessary
training
for
the
state
registered
nurses
aide.
If
a
minimum
of
80
hours
has
been
performed
in
their
their
duties
as
pcas,
they
are
all
supervised
by
licensed
and
and
or
registered,
nurses
and
and
and
those
nurses
are
in
their
certified
instructors.
A
They
must
sorry
pass
an
assessment
and
a
certification
examination,
and
I
would
just
invite
betsy
and
jessica
to
add
any
comments
at
this
time.
N
N
N
We
also
want
to
thank
eric
friedlander,
the
cabinet
secretary
and
adam
mather
and
keith
knapp,
for
working
with
us
during
the
pandemic
and
also
supporting
this
bill.
They
know
what
that
more
staff
and
long-term
care
facilities
means
more
quality
overall.
So
again
we
thank
you,
representative
moser,
for
your
leadership
and
we
urge
the
committee
to
support
house
bill
276..
Thank
you.
G
So
the
only
thing
that
I
would
offer
to
this
representative
moser
is
that
we
at
the
board
of
nursing
have
been
responsible
for
the
database
management
for
both
the
nurse
aides
and
the
pcas.
So
for
us,
the
process
will
be
very
seamless
in
monitoring
which
of
those
pcas
has
completed
the
training.
The
long-term
care
facilities
report
that
information
to
us,
then
they
would
test
as
a
normal
nurse
aide
would
through
the
kctcs
system
and
then
that
information
would
be
transmitted
to
us
to
be
put
forth
in
that
online
format.
J
Thank
you.
Thank
you
for
testimony
any
questions
representative.
L
Western
thank
you
for
the
opportunity
to
ask
this
question.
The
first
question
I
have
is:
what
are
the
duties
they
fulfill
as
as
their
job
description
and
what
is
their
salary
range.
A
I
don't
have
the
answer
to
your
question
in
terms
of
salary,
but
nurses
aides,
provide
personal
care
and
assist
nurses
in
their
duties
in
caring
for
individuals
in
the
nurses,
aids
are
used
in
long-term
care
facilities,
skilled
nursing
hospitals.
I
mean
they
really
run
the
gamut
of
of
support
staff
and
they're
wonderful
people.
They
do
do
a
yeoman's
level
of
work
in
in
just
making
sure
that
individuals
get
the
personal
care
that
they
need.
A
I
would
also
add
that
this
legislation
really
is
one
of
those
policies
that
encourages
folks
to
continue
their
education.
It's
it's
an
entry-level
nursing
position
and
these
folks
are
able
to
get
some
really
valuable
experience
and
and
of
course,
personal
gratification,
and
just
knowing
that
you're
caring
for
people
who
really
need
your
help.
But
I
I
like
this
because
it
really
is
a
step
in
creating
kind
of
that
pathway,
that
career
pathway
that
we
so
desperately
need
in
nursing,
nursing
homes
and
anywhere
that
nurses
are.
L
D
D
P
F
H
D
A
J
House,
bill
276
passes
with
favorable
expressions
to
do
so
on
the
house
floor.
Just
I
just
want
to
thank
you.
Having
worked
in
nursing
homes,
I
know
they've
probably
been
very
stressed
during
this
code
is
very
practical
and
common
sense
to
empower
people
to
move
on
to
higher
and
better
things.
So
thank
you.
I
agree.
A
Thank
you,
and
I
just
want
to
thank
jessica
for
looking
this
over
and
making
sure
that
we
we
are
putting
in
place
some
really
strong
policies.
So
thank
you
and
thank
you,
betsy
for
all
your
work.
J
A
Next,
I
would
be
delighted
to
again
I
am
representative
kim
mosher
for
the
record,
and
I
am
here
to
discuss
house
bill
307
today.
This
bill
is
simply
a
cleanup
of
house
bill,
333
from
2017
a
bill
that
I
passed
where
we
used
the
word
cannabidiol
in
reference
to
any
fda,
approved
fractured
marijuana
product
which
was
allowed
because
it
is
fda
approved
by
prescription.
A
A
Well,
I
I
think,
just
for
educational
purposes,
a
little
public
education,
it's
important
to
know
why
we're
doing
this.
So
if
you
don't
mind
just
a
couple
of
minutes,
yes,
I
I
would
agree.
Okay,
thank
you,
rebecca.
Q
Absolutely
thank
you
cheryl
mosher.
This
is
wonderful
to
be
able
to
present
this
bill,
so
I'm
rebecca
harzo
and
contract
lobbyist
for
gw
pharmaceuticals,
but
what's
important
here,
is
that
cannabinoids,
just
as
when
you
pass
2017
to
have
this
bill,
define
it
as
cannabidiol
have
been
developed
over
time
and
what
they
do
is
that
they
significantly
reduce
symptoms
for
people
with
neurological
conditions
like
epilepsy,
like
multiple
sclerosis,
and
so
all
this
hinges
on
fda
approval.
That's
what's
really
important
here,
pending
fda
approval.
Q
What
this
means
is
that
whenever
these
drugs
hit
the
market
after
they've
been
approved,
that
we
don't
lag
any
time
for
people
who
are
suffering
from
spasticity
and
other
horrendous
conditions
associated
with
neuro
neurological
diseases,
and
so
we're
just
making
sure
that
everything
is
in
place
that
as
soon
as
they're
approved
that
these
people
can
get
the
sort
of
care
and
benefit
from
these
pharmaceuticals
that
they
that
they
so
need
in
order
that
they
can
live
a
better
quality
of
life
and
bob.
You
can
also
add
to
that
as
well.
E
Well,
your
your
landmark
house
bill
333.
Four
years
ago,
representative
mosher
chairmasher
was
a
breakthrough
to
allow
the
quick
movement
of
these
really
miracle
drugs
to
get
to
people
who
need
them.
So
much
epidiolex
treats
folks
who
had
multiple
seizures
in
the
day
and
change
their
lifestyle
dramatically
with
the
ms
drug
likely
to
come
in
the
next
year.
I
would
hope
the
same
kind
of
results
could
occur
for
ms
patients
with
severe
problems
of
spasticity,
which
affects
sleep,
pain,
your
bowels
and
and
overall
life
quality
very
dramatically.
A
I,
if,
if
I
could
just
allow
mr
smith
a
few
minutes,
okay
from
the
hemp
farmers
association,
sure
thank
you.
P
Thank
you
so
much.
Madam
chair
lady.
I
appreciate
the
opportunity
to
represent
the
hardest
working
members
of
society.
I
think
the
american
farmer
and
one
of
the
things
that
I'd
like
to
point
out
with
what
we
do
as
hemp
farmers
is,
we
grow
multiple
cannabinoids
lots
and
lots
of
different
cannabinoids
that
are
associated
to
our
hemp
plant.
P
One
most
noted
two
most
noted
is
thc
and
cbd,
but
there
are
cbn
cbt,
there's
a
whole
lot
of
other
cannabinoids,
and
I
appreciate
and
applaud
chair
lady
moser
for
taking
the
time
to
learn
and
understand
the
language
between
naba,
diol
and
cannabinoids,
and
the
inclusiveness
of
more
of
the
aspects
of
our
crop
being
researched
and
hopefully
get
out
to
an
open
market,
and
that's
where
we
farmers
are
most
interested
in
moving
forward
is
new
markets,
and
I
appreciate
and
applaud
stepping
ahead
and
starting
to
let
the
groundwork
happen
for
fda
approval
of
these
cannabinoids
that
we
produce,
and
hopefully
we
will
again,
like
bob
and
rebecca
said,
help
the
folks
and
mostly
thank
you
for
the
opportunity
to
speak
today.
A
Thank
you
so
much.
I
really
appreciate
your
your
input.
I
know
how
how
what
a
difference
this
is
going
to
make
to
the
hemp
farmers
across
kentucky.
All
members
should
have
a
letter
for
the
from
the
kentucky
cannabis
association.
A
I
believe
in
your
packets
just
discussing
the
the
benefits
of
expanding
research
in
this
in
this
area.
I
will
say
that
four
years
ago
I
couldn't
even
pronounce
cannabidiol
or
cannabinoid.
I
did
not
really
know
what
they
were
and
thanks
to
martin
and
thanks
to
bob
and
his
team,
and
so
many
others,
I've
learned
a
lot.
I
think
there
are
definitely
benefits,
and
this
this
one
small
word
change,
is
going
to
make
a
huge
difference.
A
C
Thank
you,
lady
chairman.
I
have
a
comment.
You
know
when
I
first
came
to
frankfurt
on
the
first
week.
Someone
handed
me
a
bill
and
it
was
written
against
the
opioid
situation,
but
they
didn't
know
the
difference
between
opiate
and
opioids
words
matter,
and
so
just
like
this.
This
would
extend
some
research.
C
We
know
that
there's
some
research
being
done
at
yale,
even
though
it's
still
schedule
one
on
marijuana.
It's
been
approved
by
the
dea,
and
we
see
this
as
an
opportunity
for
more
industry
agricultural
industry
in
kentucky.
I
am
not
against
safety
and
efficacy
of
a
product.
Just
like
senator
representative
moser
give
you
a
pay
grade.
Increase
we've
always
talked
about
this,
we're
not
against
it.
C
We're
for
safety
and
I've
said
it
a
million
times
the
first
section
of
the
kentucky
constitution
we
take
an
oath
to
as
the
word
safety
in
it,
and
if
you
do
safety
and
efficacy,
you
come
back
with
this
and
we
you're
going
to
increase
your
business,
and
I'm
just
glad
to
hear
that
you
know
so.
Everybody
knows
me
if
it's
safety
and
efficiency
I'll
vote
yes
on.
If
it's
not
I'll
vote.
No
one,
thank
you.
Thank
you.
Late
chairman.
J
Thank
you.
We've
had
first
and
second,
madam
secretary,
take
the
role.
C
D
F
F
F
N
D
L
A
J
House,
bill
307
passes
with
favorable
expression
and
should
do
so
on
the
house
floor.
I
just
want
to
say
that
I
have
been
lobbied
by
ella's
daughter,
she's,
a
good
friend
of
adrian
polyniak,
for
several
years
I've
been
over
to
midway
close
to
where
their
office
is,
and
so
thank
you
again
for
bringing
such
a
good
piece
of
legislation.
D
E
No,
I
think
they
get
it.
I
think
the
fundamentals
come
across
and
and
they
you
know,
we
don't
get
the
crazy.
Is
this
medical
marijuana
or
what
the
hell
are
you
doing
or
all
that
kind
of
thing.
E
Yeah,
I
thought
we
captured
it
well,
and
martin
was
very
reasonable.
So
so
what
a
day,
what
a
freaking
day?
Yes,
you've
gone
from
chemical
manufacturing
to
athletic
training
to
pharmacological
advancement.